Literature DB >> 6116201

Vanadate inhibition of brain (Ca + Mg)-ATPase.

J D Robinson.   

Abstract

Vanadate was a potent inhibitor of the membrane-bound (Ca + Mg)-ATPase from rat brain, the concentration required for 50% inhibition under conditions optimal for enzymatic activity being 3 mu M. Vanadate inhibition increased with the MgCl2 concentration, half-maximal inhibition occurring at 2 mM MgCl2, near the MgCl2 concentration required for half-maximal activation of the ATPase activity. MnCl2 could substitute for MgCl2, and at concentrations of 1 mM (Ca + Mn)-ATPase activity was greater than (Ca + Mg)-ATPase activity, although sensitivity to vanadate was less. Vanadate inhibition increased also with the KCl concentration, half-maximal inhibition occurring at 8 mM, again near the concentration required for half-maximal activation of ATPase activity. By contrast, NaCl stimulated (Ca + Mg)-ATPase activity without potentiating vanadate inhibition. These effects of cations on ATPase activity and vanadate inhibition resemble properties of certain transport ATPases and thus suggest mechanistic and functional similarities.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116201     DOI: 10.1007/bf00964038

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  15 in total

1.  (Ca + Mg)-stimulated ATPase activity of a rat brain microsomal preparation.

Authors:  J D Robinson
Journal:  Arch Biochem Biophys       Date:  1976-09       Impact factor: 4.013

2.  Adenosine 5'-triphosphate-orthophosphate exchange catalyzed by the Ca2+-transport ATPase of brain. Activation by a small transmembrane Ca2+ gradient.

Authors:  E E Trotta; L de Meis
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

3.  Reconstitution and purification by "transport specificity fractionation" of an ATP-dependent calcium transport component from synaptosome-derived vesicles.

Authors:  D Papazian; H Rahamimoff; S M Goldin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Calcium transport in a vesicular membrane preparation from rat brain synaptosomes.

Authors:  H Rahamimoff; E Abramovitz
Journal:  FEBS Lett       Date:  1978-05-15       Impact factor: 4.124

5.  Vanadate--a new tool for biologists.

Authors:  T J Simons
Journal:  Nature       Date:  1979-10-04       Impact factor: 49.962

6.  A characterization of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory implications.

Authors:  L C Cantley; L G Cantley; L Josephson
Journal:  J Biol Chem       Date:  1978-10-25       Impact factor: 5.157

7.  Effects of potassium on vanadate inhibition of sarcoplasmic reticulum Ca2+-ATPase from dog cardiac and rabbit skeletal muscle.

Authors:  T Wang; L I Tsai; R J Solaro; A O Grassi de Gende; A Schwartz
Journal:  Biochem Biophys Res Commun       Date:  1979-11-14       Impact factor: 3.575

8.  Vanadate inhibits uncoupled Ca efflux but not Na--Ca exchange in squid axons.

Authors:  R DiPolo; H R Rojas; L Beaugé
Journal:  Nature       Date:  1979-09-20       Impact factor: 49.962

9.  Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle.

Authors:  L C Cantley; L Josephson; R Warner; M Yanagisawa; C Lechene; G Guidotti
Journal:  J Biol Chem       Date:  1977-11-10       Impact factor: 5.157

10.  Activation of calcium transport in skeletal muscle sarcoplasmic reticulum by monovalent cations.

Authors:  M Shigekawa; L J Pearl
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

View more
  3 in total

1.  Calcium efflux and cycling across the synaptosomal plasma membrane.

Authors:  R Snelling; D Nicholls
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

2.  Substrate interactions with brain (Ca + Mg)-ATPase.

Authors:  J D Robinson
Journal:  Neurochem Res       Date:  1982-11       Impact factor: 3.996

3.  Localization of endogenous ATPases at the nerve terminal.

Authors:  R G Sorensen; H R Mahler
Journal:  J Bioenerg Biomembr       Date:  1982-12       Impact factor: 2.945

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.